Loading…
Based on limited metadata, this FDA Warning Letter issued to Indus Medicare Limited on May 4, 2020, addresses compliance concerns related to medical devices. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's medical device regulatory jurisdiction, though the specific issuing office and violation details remain unknown. This letter indicates that the agency identified regulatory deficiencies requiring corrective action by the company.